5 of 7
A bright smile dazzles the judges
A bright smile dazzles the judges
CEO Mike Lowe (left) and VP of Clinical Affairs and Technology Brent Tarver.
IP Powerhouse Award, Rice Business Plan Competition 2006

Business plan competitions don't just pay off for the top winners - they're also hotspots for networking with business veterans who might take an interest in your idea. Or buy it outright.

That's what happened to the OrthoAccel team following Rice's competition. For an undisclosed price, the team sold its intellectual property to a judge who has continued advancing the technology toward commercialization. None of the original founders remain, but today OrthoAccel has a working product: A mouth device that vibrates teeth and delivers pulsating forces that can expedite teeth realignment treatments, such as braces, when worn for 10 to 20 minutes a day. In animal trials, the technology cut the treatment time in half.

The first human trial just finished last month, and though the data is still being analyzed, OrthoAccel CEO Michael Lowe says the product - which doesn't yet have a name - appears to be both safe and effective. The company is now in its second human trial, which Lowe anticipates will result in FDA clearance. OrthoAccel can't sell in the U.S. just yet, but it has started the process of introducing its product to the European market and plans a full launch overseas in September.

NEXT: Cleaning up in the medical market

Email | Print | Share  |  RSS
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)
LAST UPDATE: Aug 24 2009 | 3:29 PM ET
Sponsored by
Meet the competitors Dozens of aspiring entrepreneurs will vie for a share of $800,000 in seed money at this month's Rice Business Plan Competition. More
6 ideas for changing the world Do good and make money: That's the goal of these six startups vying for the Social Venture Award and $10,000 in seed money. More
10 steps to catch VC cash Follow our 10-point guide to landing the right investors. More